Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system

Nature Genetics

Volumn 25, Issue 1, 2000, Pages 35-41

  Yant, Stephen R ^a,b   Meuse, Leonard ^a   Chiu, Winnie ^a   Ivics, Zoltan ^c   Izsvak, Zsuzsanna ^c,d   Kay, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; DNA; MESSENGER RNA; VIRUS VECTOR;

ANIMAL MODEL; ARTICLE; GENE EXPRESSION; GENE THERAPY; GENOME; HEMOPHILIA; HEMOPHILIA B; LIVER CELL; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; DISEASE SUSCEPTIBILITY; DNA TRANSPOSABLE ELEMENTS; DNA-BINDING PROTEINS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HELA CELLS; HEMOPHILIA B; HUMANS; INJECTIONS, INTRAVENOUS; LIVER; MICE; MICE, INBRED C57BL; MICE, SCID; MOLECULAR SEQUENCE DATA; PLASMIDS; TRANSGENES; TRANSPOSASES;

ANIMALIA; MAMMALIA; MUS MUSCULUS; RODENTIA;

EID: 0034103009     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/75568     Document Type: Article

References (50)

1. Kovesdi, I., Brough, D.E., Bruder, J.T. & Wickham, T.J. Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol. 8, 583-589 (1997).
2. Latchman, D.S. Herpes simplex virus vectors for gene therapy. Mol. Biotechnol. 2, 179-195 (1994).
3. Gordon, E.M. & Anderson, W.F. Gene therapy using retroviral vectors. Curr. Opin. Biotechnol. 5, 611-616 (1994).
4. Naldini, L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol 9, 457-463 (1998).
5. Rabinowitz, J.E. & Samulski, J. Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol. 9, 470-475 (1998).
6. Kay, M.A. et al. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262, 117-119 (1993).
7. Miao, C.H. et al. The kinetics of rAAV integration in the liver. Nature Genet. 19, 13-15 (1998).
8. Snyder, R.O. et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nature Med. 5, 64-70(1999).
9. Nakai, H., Iwaki, Y., Kay, M.A. & Couto, L.B. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73, 5438-5447 (1999).
10. Park, F., Ohashi, K., Chiu, W., Naldini, L. & Kay, M.A. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nature Genet. 24, 49-52 (2000).
11. Zhu, J. et al. Characterization of replication-competent adenoviral isolates from large-scale production of a recombinant adenoviral vector. Hum. Gene Ther. 10, 113-121 (1999).
12. Yang, Y., Li, Q., Ertl, H.C. & Wilson, J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015 (1995).
13. Kay, M.A. et al. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4lg enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc. Natl Acad. Sci. USA 94, 4684-4691 (1997).
14. Hernandez, Y.J. et al. Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model. J. Virol. 73, 8549-8558 (1999).
15. Liu, F., Song, Y.K. & Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258-1266(1999).
16. Zhang, G., Budker, V. & Wolff, J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735-1737 (1999).
17. Yew, N.S. et al. Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum. Gene Ther. 8, 575-584 (1997).
18. Wolff, J.A. et al. Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468 (1990).
19. Choate, K.A. & Khavari, P.A. Direct cutaneous gene delivery in a human genetic skin disease. Hum. Gene Ther. 8, 1659-1665 (1997).
20. Li, K., Welikson, R.E., Vikstrom, K.L. & Leinwand, L.A. Direct gene transfer into the mouse heart. J. Mol. Cell. Cardiol. 29, 1499-1504 (1997).
21. Alino, S.F. et al. Expression of human α-1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes. Biochem. Biophys. Res. Comm. 204, 1023-1030 (1994).
22. Caplen, N.J. et al. Liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39-46 (1995).
23. Mumper, R.J. et al. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res. 13, 701-709 (1996).
24. Perales, J.C., Ferkol, T., Molas, M. & Hanson, R.W. An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. Eur. J. Biochem. 226, 255-266 (1994).
25. Plasterk, R.H.A. The Tc1/mariner transposon family. Curr. Top. Microbiol. Immunol. 204, 125-143 (1996).
26. Lampe, D.J., Churchill, M.E.A. & Robertson, H.M. A purified mariner transposase is sufficient to mediate transposition in vitro. EMBO J. 15, 5470-5479(1996).
27. Vos, J.C., De Baere, I. & Plasterk, R.H.A. Transposase is the only nematode protein required for in vitro transposition of Tc1. Genes Dev. 10, 755-761 (1996).
28. Coates, C.J., Jasinskiene, N., Miyashiro, L. & James, A.A. Mariner transposition and transformation of the yellow fever mosquito, Aedes aegypti. Proc. Natl Acad. Sci. USA 95, 3748-3751 (1998).
29. Raz, E., van Luenen, H.G., Schaerringer, B. & Plasterk, R.H.A. Transposition of the nematode Caenorhabditis elegans Tc3 element in the zebrafish Danio rerio. Curr. Biol. 8, 82-88 (1998).
30. Sherman, A. et al. Transposition of the Drosophila element mariner into the chicken germ line. Nature Biotechnol. 16, 1013-1017 (1998).
31. Ivics, Z., Hackett, P.B., Plasterk, R.H. & Izsvak, Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91, 501-510 (1997).
32. Luo, G., Ivics, Z., Izsvak, Z. & Bradley, A. Chromosomal transposition of a Tcl/mariner-like element in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 95, 10769-10773 (1998).
33. Lohe, A.R., Aguiar, D.D. & Hartl, D.L. Mutations in the mariner transposase: the D,D(35)E consensus sequence is nonfunctional Proc Natl Acad. Sci. USA 94, 1293-1297 (1997).
34. Kafri, T., Blomer, U., Peterson, D.A., Gage, F.H. & Verma, I.M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genet. 17, 314-317 (1997).
35. Koeberl, D.O., Alexander, I.E., Halbert, C.L., Russell, D.W. & Miller, A.D. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl Acad. Sci. USA 94, 1426-1431 (1997).
36. Xiao, W. et al. Adeno-associated virus as a vector for liver-directed gene therapy. J. Virol. 72, 10222-10226 (1998).
37. Miao, C.H. et al. Non-random transduction of recombinant adeno-associated viral vectors in mouse hepatocytes in vivo: cell cycling is not required for transduction. J. Virol. 74, 3793-3803 (2000).
38. Reiner, A.P. & Davie, E.W. in The Metabolic and Molecular Basis of Inherited Disease (eds Scriver, C R., Beaudet, A.L., Sly, W.S. & Valle, D.) (McGraw-Hill, New York, 1995).
39. Lampe, D.J., Grant, T.E. & Robertson, H.M. Factors affecting transposition of the Himar1 mariner transposon in vitro. Genetics 149, 179-187 (1998).
40. Hartl, D.L., Lozovskaya, E.R., Nurminsky, D.I. & Lohe, A.R. What restricts the activity of mariner-like transposable elements? Trends Genet. 13, 197-201 (1997).
41. Lohe, A.R., Sullivan, D.T. & Hartl, D.L. Subunit interactions in the mariner transposase. Genetics 144, 1087-1095 (1996).
42. Lin, H.F., Maeda, N., Smithies, O., Straight, D.L. & Stafford, D.W. A coagulation factor IX-deficient mouse model for human hemophilia B. Nature Med. 90, 3962-3966 (1997).
43. Kay, M.A. & Fausto, N. Liver regeneration: prospects for therapy based on new technologies. Mol. Med. Today 3, 108-115 (1997).
44. Zhang, L., Sankar, U., Lampe, D.J., Robertson, H.M. & Graham, F.L. The Himarl mariner transposase cloned in a recombinant adenovirus vector is functional in mammalian cells. Nucleic Acids Res. 26, 3687-3693 (1998).
45. Schouten, G.J., van Luenen, H.G., Verra, N.C., Valerio, D. & Plasterk, R.H. Transposon Tc1 of the nematode Caenorhabditis elegans jumps in human cells. Nucleic Acids Res. 26, 3013-3017 (1998).
46. Plasterk, R.H.A., Izsvak, Z. & Ivics, Z. Resident aliens. Trends Genet. 15, 326-332 (1999).
47. Kay, M.A., Graham, F., Leland, F. & Woo, S.L.C. Therapeutic serum concentrations of human α-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21, 815-819 (1995).
48. Walter, J., You, Q., Hagstrom, J.N., Sands, M. & High, K.A. Successful expression of human factor IX following repeat administration of adenoviral vector in mice. Proc. Natl Acad. Sci. USA 93, 3056-3061 (1996).
49. Lieber, A., He, C.-Y., Kirllova, I. & Kay, M.A. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70, 8944-8960 (1996).
50. Rutledge, E.A. & Russell, D.W. Adeno-associated virus vector integration junctions. J. Virol. 71, 8429-8436 (1997).